The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
The global Gastrointestinal Drugs market size is expected to reach US$ 43470 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Gastrointestinal Drugs in various end use industries. The expanding demands from the Chronic Gastritis, Functional Dyspepsia, Peptic Ulcer and Acute Gastroenteritis, are propelling Gastrointestinal Drugs market. Prescription Gastrointestinal Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the OTC Gastrointestinal Drug segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gastrointestinal Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gastrointestinal Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gastrointestinal Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gastrointestinal Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gastrointestinal Drugs covered in this report include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria (Tillotts), Perrigo and Boehringer Ingelheim, etc.
The global Gastrointestinal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- AstraZeneca
- Sanofi
- Bayer
- Pfizer
- GlaxoSmithKline
- Teva
- Zeria (Tillotts)
- Perrigo
- Boehringer Ingelheim
- Purdue Pharma
- C.B. Fleet
- Abbott
- Jiangzhong
- Xian-Janssen
Global Gastrointestinal Drugs market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gastrointestinal Drugs market, Segment by Type:
- Prescription Gastrointestinal Drug
- OTC Gastrointestinal Drug
Global Gastrointestinal Drugs market, by Application
- Chronic Gastritis
- Functional Dyspepsia
- Peptic Ulcer
- Acute Gastroenteritis
- Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gastrointestinal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Gastrointestinal Drugs Market Overview
1.1 Gastrointestinal Drugs Product Overview
1.2 Gastrointestinal Drugs Market Segment by Type
1.2.1 Prescription Gastrointestinal Drug
1.2.2 OTC Gastrointestinal Drug
1.3 Global Gastrointestinal Drugs Market Size by Type
1.3.1 Global Gastrointestinal Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Gastrointestinal Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Gastrointestinal Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gastrointestinal Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Gastrointestinal Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Gastrointestinal Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Gastrointestinal Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Gastrointestinal Drugs Sales Breakdown by Type (2018-2023)
2 Global Gastrointestinal Drugs Market Competition by Company
2.1 Global Top Players by Gastrointestinal Drugs Sales (2018-2023)
2.2 Global Top Players by Gastrointestinal Drugs Revenue (2018-2023)
2.3 Global Top Players by Gastrointestinal Drugs Price (2018-2023)
2.4 Global Top Manufacturers Gastrointestinal Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gastrointestinal Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Gastrointestinal Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Gastrointestinal Drugs Market
2.8 Key Manufacturers Gastrointestinal Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gastrointestinal Drugs Status and Outlook by Region
3.1 Global Gastrointestinal Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gastrointestinal Drugs Historic Market Size by Region
3.2.1 Global Gastrointestinal Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Gastrointestinal Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Gastrointestinal Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Gastrointestinal Drugs Forecasted Market Size by Region
3.3.1 Global Gastrointestinal Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Gastrointestinal Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Gastrointestinal Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gastrointestinal Drugs by Application
4.1 Gastrointestinal Drugs Market Segment by Application
4.1.1 Chronic Gastritis
4.1.2 Functional Dyspepsia
4.1.3 Peptic Ulcer
4.1.4 Acute Gastroenteritis
4.1.5 Other
4.2 Global Gastrointestinal Drugs Market Size by Application
4.2.1 Global Gastrointestinal Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Gastrointestinal Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Gastrointestinal Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gastrointestinal Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Gastrointestinal Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Gastrointestinal Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Gastrointestinal Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Gastrointestinal Drugs Sales Breakdown by Application (2018-2023)
5 North America Gastrointestinal Drugs by Country
5.1 North America Gastrointestinal Drugs Historic Market Size by Country
5.1.1 North America Gastrointestinal Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gastrointestinal Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Gastrointestinal Drugs Sales in Value by Country (2018-2023)
5.2 North America Gastrointestinal Drugs Forecasted Market Size by Country
5.2.1 North America Gastrointestinal Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Gastrointestinal Drugs Sales in Value by Country (2024-2029)
6 Europe Gastrointestinal Drugs by Country
6.1 Europe Gastrointestinal Drugs Historic Market Size by Country
6.1.1 Europe Gastrointestinal Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gastrointestinal Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Gastrointestinal Drugs Sales in Value by Country (2018-2023)
6.2 Europe Gastrointestinal Drugs Forecasted Market Size by Country
6.2.1 Europe Gastrointestinal Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Gastrointestinal Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Gastrointestinal Drugs by Region
7.1 Asia-Pacific Gastrointestinal Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Gastrointestinal Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gastrointestinal Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Gastrointestinal Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Gastrointestinal Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Gastrointestinal Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gastrointestinal Drugs Sales in Value by Region (2024-2029)
8 Latin America Gastrointestinal Drugs by Country
8.1 Latin America Gastrointestinal Drugs Historic Market Size by Country
8.1.1 Latin America Gastrointestinal Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gastrointestinal Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Gastrointestinal Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Gastrointestinal Drugs Forecasted Market Size by Country
8.2.1 Latin America Gastrointestinal Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gastrointestinal Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Gastrointestinal Drugs by Country
9.1 Middle East and Africa Gastrointestinal Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Gastrointestinal Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gastrointestinal Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Gastrointestinal Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Gastrointestinal Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Gastrointestinal Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gastrointestinal Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Gastrointestinal Drugs Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Gastrointestinal Drugs Products Offered
10.2.5 Sanofi Recent Development
10.3 Bayer
10.3.1 Bayer Company Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bayer Gastrointestinal Drugs Products Offered
10.3.5 Bayer Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Gastrointestinal Drugs Products Offered
10.4.5 Pfizer Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GlaxoSmithKline Gastrointestinal Drugs Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Teva
10.6.1 Teva Company Information
10.6.2 Teva Introduction and Business Overview
10.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Gastrointestinal Drugs Products Offered
10.6.5 Teva Recent Development
10.7 Zeria (Tillotts)
10.7.1 Zeria (Tillotts) Company Information
10.7.2 Zeria (Tillotts) Introduction and Business Overview
10.7.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zeria (Tillotts) Gastrointestinal Drugs Products Offered
10.7.5 Zeria (Tillotts) Recent Development
10.8 Perrigo
10.8.1 Perrigo Company Information
10.8.2 Perrigo Introduction and Business Overview
10.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Perrigo Gastrointestinal Drugs Products Offered
10.8.5 Perrigo Recent Development
10.9 Boehringer Ingelheim
10.9.1 Boehringer Ingelheim Company Information
10.9.2 Boehringer Ingelheim Introduction and Business Overview
10.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Boehringer Ingelheim Gastrointestinal Drugs Products Offered
10.9.5 Boehringer Ingelheim Recent Development
10.10 Purdue Pharma
10.10.1 Purdue Pharma Company Information
10.10.2 Purdue Pharma Introduction and Business Overview
10.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Purdue Pharma Gastrointestinal Drugs Products Offered
10.10.5 Purdue Pharma Recent Development
10.11 C.B. Fleet
10.11.1 C.B. Fleet Company Information
10.11.2 C.B. Fleet Introduction and Business Overview
10.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 C.B. Fleet Gastrointestinal Drugs Products Offered
10.11.5 C.B. Fleet Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Abbott Gastrointestinal Drugs Products Offered
10.12.5 Abbott Recent Development
10.13 Jiangzhong
10.13.1 Jiangzhong Company Information
10.13.2 Jiangzhong Introduction and Business Overview
10.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Jiangzhong Gastrointestinal Drugs Products Offered
10.13.5 Jiangzhong Recent Development
10.14 Xian-Janssen
10.14.1 Xian-Janssen Company Information
10.14.2 Xian-Janssen Introduction and Business Overview
10.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Xian-Janssen Gastrointestinal Drugs Products Offered
10.14.5 Xian-Janssen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gastrointestinal Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gastrointestinal Drugs Industrial Chain Analysis
11.4 Gastrointestinal Drugs Market Dynamics
11.4.1 Gastrointestinal Drugs Industry Trends
11.4.2 Gastrointestinal Drugs Market Drivers
11.4.3 Gastrointestinal Drugs Market Challenges
11.4.4 Gastrointestinal Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gastrointestinal Drugs Distributors
12.3 Gastrointestinal Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
